Search

everythinglearnresearchcommunity

for

Search:↓

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Hair follicles help attract immune cells to the skin during stress.

Hair follicles could help develop eye treatments by studying immune responses.

Alopecia patients have higher heart disease risk; statins and finasteride may help.

Early treatment with immunoglobulin and aspirin reduces heart complications in children with Kawasaki disease.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

Calcipotriol's effectiveness for treating alopecia areata is unclear and needs more research.

Damaged hair follicles make mice more prone to skin inflammation and skin cancer after UV exposure.

Cellular and immunotherapies show promise for healing chronic wounds but need more research.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Modified rat stem cells on a special scaffold improved blood vessel formation and wound healing in skin substitutes.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Alopecia areata can cause unpredictable hair loss, and treatments like corticosteroids and minoxidil may help but have varying side effects.

Researchers identified five new potential targets for leishmaniasis treatment, suggesting repurposing existing drugs could be effective.

Human skin can provide stem cells for tissue repair and regeneration, but there are challenges in obtaining and growing these cells safely.

The conclusion is that women are heavily affected by autoimmune skin diseases, face significant challenges, and need better research, treatments, and healthcare policies.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

MSC-Exos can aid organ development and offer therapeutic benefits for various conditions.

COVID-19 vaccination does not significantly increase the risk of developing alopecia areata.

Cannabinoids may help treat various skin conditions.

COVID-19 infection may trigger alopecia areata in some patients.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.